Related Experiment Videos
Light-induced mechanisms for nanocarrier's cargo release.
Ana Sanchis1, J-Pablo Salvador1, M-Pilar Marco1
1Nanobiotechnology for diagnostics group (Nb4D), Department of Chemical and Biomolecular Nanotechnology, Institute for Advanced Chemistry of Catalonia (IQAC) of the Spanish Council for Scientific Research (CSIC), Spain; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Jordi Girona 18-26, 08034 Barcelona, Spain.
Colloids and Surfaces. B, Biointerfaces
|December 16, 2018
Summary
This review explores how external stimuli can trigger controlled release from nanocarriers for improved drug delivery and diagnostics. It highlights advancements in nanomaterial applications for enhanced therapeutic efficacy and disease monitoring.
Area of Science:
- Nanotechnology
- Biomedicine
- Materials Science
Background:
- Nanomaterials offer novel properties for applications in biomedicine, electronics, and catalysis.
- In diagnostics, nanomaterials enhance sensitivity and response times for early disease detection and monitoring.
- For therapeutics, nanocarriers aim for efficient, selective, and controlled drug delivery to maximize efficacy and minimize side effects.
Purpose of the Study:
- To discuss external stimuli that trigger controlled release of biomolecules from nanocarriers.
- To review the physical principles, basic concepts, and examples of different nanocarrier classes.
- To present a discussion on the implications and future prospects for optimal drug delivery systems and diagnostic applications.
Main Methods:
- Literature review and synthesis of existing research on nanocarrier-based drug delivery.
- Categorization of nanocarriers based on stimuli-responsive release mechanisms.
- Analysis of physical principles and examples for each class of nanocarriers.
Main Results:
- Nanocarriers can be designed for controlled release of therapeutic agents via various mechanisms.
- External stimuli (e.g., pH, temperature, magnetic fields) can be utilized to trigger drug release.
- Different nanocarrier generations offer diverse applications in both diagnostics and therapeutics.
Conclusions:
- Optimizing nanocarrier design for stimuli-responsive drug release is crucial for therapeutic success.
- Future trends indicate significant potential for advanced nanodiagnostics and targeted drug delivery systems.
- Further research is needed to fully realize the clinical implications of these advanced nanomaterial systems.